Robeco Institutional Asset Management B.V. Acquires 40,905 Shares of Cardinal Health, Inc. $CAH

Robeco Institutional Asset Management B.V. increased its holdings in shares of Cardinal Health, Inc. (NYSE:CAH) by 3.8% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 1,130,814 shares of the company’s stock after purchasing an additional 40,905 shares during the period. Robeco Institutional Asset Management B.V. owned 0.49% of Cardinal Health worth $251,606,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors have also recently added to or reduced their stakes in the business. Prime Capital Investment Advisors LLC boosted its holdings in Cardinal Health by 3.5% in the 3rd quarter. Prime Capital Investment Advisors LLC now owns 7,859 shares of the company’s stock worth $1,749,000 after acquiring an additional 264 shares during the period. Focused Alpha LLC raised its stake in shares of Cardinal Health by 6.4% during the third quarter. Focused Alpha LLC now owns 2,900 shares of the company’s stock valued at $645,000 after purchasing an additional 175 shares during the period. Sumitomo Mitsui DS Asset Management Company Ltd raised its stake in shares of Cardinal Health by 2.1% during the third quarter. Sumitomo Mitsui DS Asset Management Company Ltd now owns 33,457 shares of the company’s stock valued at $7,444,000 after purchasing an additional 674 shares during the period. Secure Asset Management LLC lifted its position in shares of Cardinal Health by 1.6% during the third quarter. Secure Asset Management LLC now owns 4,422 shares of the company’s stock worth $984,000 after purchasing an additional 68 shares in the last quarter. Finally, Clark Financial Services Group Inc. BD lifted its position in shares of Cardinal Health by 7.8% during the third quarter. Clark Financial Services Group Inc. BD now owns 4,941 shares of the company’s stock worth $1,099,000 after purchasing an additional 356 shares in the last quarter. 87.17% of the stock is owned by hedge funds and other institutional investors.

Cardinal Health Stock Up 1.8%

Shares of NYSE CAH opened at $257.15 on Wednesday. Cardinal Health, Inc. has a fifty-two week low of $156.81 and a fifty-two week high of $258.30. The business has a 50 day moving average price of $235.21 and a two-hundred day moving average price of $222.94. The firm has a market cap of $59.54 billion, a PE ratio of 35.57, a price-to-earnings-growth ratio of 1.52 and a beta of 0.50.

Cardinal Health (NYSE:CAH) last announced its earnings results on Tuesday, August 11th. The company reported $2.91 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.42 by $0.49. The company had revenue of $63.67 billion for the quarter, compared to analyst estimates of $65.15 billion. Cardinal Health had a negative return on equity of 98.53% and a net margin of 0.67%. Cardinal Health’s quarterly revenue was up 5.8% on a year-over-year basis. During the same period in the prior year, the company posted $2.08 EPS. Cardinal Health has set its FY 2027 guidance at 12.400-12.600 EPS. On average, analysts anticipate that Cardinal Health, Inc. will post 12.55 earnings per share for the current year.

Cardinal Health Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Thursday, October 15th. Investors of record on Thursday, October 1st were issued a $0.5158 dividend. The ex-dividend date of this dividend was Thursday, October 1st. This represents a $2.06 annualized dividend and a yield of 0.8%. Cardinal Health’s dividend payout ratio is currently 28.49%.

Insider Transactions at Cardinal Health

In other Cardinal Health news, CEO Deborah Weitzman sold 7,354 shares of the firm’s stock in a transaction on Tuesday, August 18th. The shares were sold at an average price of $235.45, for a total transaction of $1,731,499.30. Following the completion of the transaction, the chief executive officer directly owned 77,901 shares of the company’s stock, valued at $18,341,790.45. This trade represents a 8.63% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Michelle D. Greene sold 11,650 shares of the business’s stock in a transaction dated Tuesday, August 18th. The stock was sold at an average price of $235.72, for a total transaction of $2,746,138.00. Following the completion of the sale, the insider directly owned 10,330 shares of the company’s stock, valued at $2,434,987.60. The trade was a 53.00% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold a total of 210,271 shares of company stock valued at $49,626,657 over the last ninety days. 0.12% of the stock is currently owned by corporate insiders.

Wall Street Analysts Forecast Growth

Several research analysts have recently weighed in on the stock. Robert W. Baird upped their target price on shares of Cardinal Health from $251.00 to $274.00 and gave the company an “outperform” rating in a research note on Wednesday, August 12th. Bank of America lifted their price target on shares of Cardinal Health from $240.00 to $260.00 and gave the stock a “buy” rating in a research note on Thursday, July 2nd. Barclays lifted their price target on shares of Cardinal Health from $258.00 to $275.00 and gave the stock an “overweight” rating in a research note on Thursday, August 13th. Morgan Stanley boosted their price objective on shares of Cardinal Health from $255.00 to $265.00 and gave the stock an “overweight” rating in a report on Wednesday, August 12th. Finally, TD Cowen upped their price objective on shares of Cardinal Health from $275.00 to $280.00 and gave the company a “buy” rating in a research report on Thursday, August 13th. Sixteen investment analysts have rated the stock with a Buy rating and three have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $269.38.

About Cardinal Health

Cardinal Health, Inc is a healthcare services and products company that supports the distribution and delivery of pharmaceuticals, medical products and related services. The company serves hospitals, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices and other healthcare providers.

Its Pharmaceutical and Specialty Solutions segment distributes branded, generic and specialty pharmaceuticals, as well as consumer health products, to pharmacies and healthcare institutions.